Kit for detecting early liver cancer
The invention discloses a kit for detecting early liver cancer, relates to the technical field of biomedicine, and determines whether an individual has a liver cancer condition by detecting the levels of ACY1 and GP73 in an individual sample. The two molecules ACY1 and GP73 are used as a combination...
Gespeichert in:
| Hauptverfasser: | , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | WEI XUYONG WU JIAPING XU XIAO SU RENYI PAN BINHUA SHU WENZHI |
| description | The invention discloses a kit for detecting early liver cancer, relates to the technical field of biomedicine, and determines whether an individual has a liver cancer condition by detecting the levels of ACY1 and GP73 in an individual sample. The two molecules ACY1 and GP73 are used as a combination to detect the expression levels of the two biomolecules in the plasma of a liver cancer individual to be diagnosed, early-stage liver cancer patients can be effectively screened, the combined detection is also sensitive to individuals with negative AFP antibody expression, the detection sensitivity is 94.9%, and the specificity reaches 89.3%.
本发明公开了一种用于检测早期肝癌的试剂盒，涉及生物医学技术领域，其通过检测个体样本中ACY1和GP73的水平来确定个体是否有肝癌状况。本发明将ACY1和GP73这2种分子作为一个组合，检测待确诊肝癌个体血浆中两种生物分子的表达水平，可以有效筛查肝癌早期患者，且该联合检测，对AFP抗体表达阴性的个体也较为灵敏，其检测灵敏度为94.9％，特异性达到89.3％。 |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_CN115754290A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>CN115754290A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_CN115754290A3</originalsourceid><addsrcrecordid>eNrjZFDxzixRSMsvUkhJLUlNLsnMS1dITSzKqVTIySxLLVJITsxLTi3iYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxzn6GhqbmpiZGlgaOxsSoAQDt7iaA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Kit for detecting early liver cancer</title><source>esp@cenet</source><creator>WEI XUYONG ; WU JIAPING ; XU XIAO ; SU RENYI ; PAN BINHUA ; SHU WENZHI</creator><creatorcontrib>WEI XUYONG ; WU JIAPING ; XU XIAO ; SU RENYI ; PAN BINHUA ; SHU WENZHI</creatorcontrib><description>The invention discloses a kit for detecting early liver cancer, relates to the technical field of biomedicine, and determines whether an individual has a liver cancer condition by detecting the levels of ACY1 and GP73 in an individual sample. The two molecules ACY1 and GP73 are used as a combination to detect the expression levels of the two biomolecules in the plasma of a liver cancer individual to be diagnosed, early-stage liver cancer patients can be effectively screened, the combined detection is also sensitive to individuals with negative AFP antibody expression, the detection sensitivity is 94.9%, and the specificity reaches 89.3%.
本发明公开了一种用于检测早期肝癌的试剂盒，涉及生物医学技术领域，其通过检测个体样本中ACY1和GP73的水平来确定个体是否有肝癌状况。本发明将ACY1和GP73这2种分子作为一个组合，检测待确诊肝癌个体血浆中两种生物分子的表达水平，可以有效筛查肝癌早期患者，且该联合检测，对AFP抗体表达阴性的个体也较为灵敏，其检测灵敏度为94.9％，特异性达到89.3％。</description><language>chi ; eng</language><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES ; MEASURING ; PHYSICS ; TESTING</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230307&DB=EPODOC&CC=CN&NR=115754290A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230307&DB=EPODOC&CC=CN&NR=115754290A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>WEI XUYONG</creatorcontrib><creatorcontrib>WU JIAPING</creatorcontrib><creatorcontrib>XU XIAO</creatorcontrib><creatorcontrib>SU RENYI</creatorcontrib><creatorcontrib>PAN BINHUA</creatorcontrib><creatorcontrib>SHU WENZHI</creatorcontrib><title>Kit for detecting early liver cancer</title><description>The invention discloses a kit for detecting early liver cancer, relates to the technical field of biomedicine, and determines whether an individual has a liver cancer condition by detecting the levels of ACY1 and GP73 in an individual sample. The two molecules ACY1 and GP73 are used as a combination to detect the expression levels of the two biomolecules in the plasma of a liver cancer individual to be diagnosed, early-stage liver cancer patients can be effectively screened, the combined detection is also sensitive to individuals with negative AFP antibody expression, the detection sensitivity is 94.9%, and the specificity reaches 89.3%.
本发明公开了一种用于检测早期肝癌的试剂盒，涉及生物医学技术领域，其通过检测个体样本中ACY1和GP73的水平来确定个体是否有肝癌状况。本发明将ACY1和GP73这2种分子作为一个组合，检测待确诊肝癌个体血浆中两种生物分子的表达水平，可以有效筛查肝癌早期患者，且该联合检测，对AFP抗体表达阴性的个体也较为灵敏，其检测灵敏度为94.9％，特异性达到89.3％。</description><subject>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</subject><subject>MEASURING</subject><subject>PHYSICS</subject><subject>TESTING</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZFDxzixRSMsvUkhJLUlNLsnMS1dITSzKqVTIySxLLVJITsxLTi3iYWBNS8wpTuWF0twMim6uIc4euqkF-fGpxQWJyal5qSXxzn6GhqbmpiZGlgaOxsSoAQDt7iaA</recordid><startdate>20230307</startdate><enddate>20230307</enddate><creator>WEI XUYONG</creator><creator>WU JIAPING</creator><creator>XU XIAO</creator><creator>SU RENYI</creator><creator>PAN BINHUA</creator><creator>SHU WENZHI</creator><scope>EVB</scope></search><sort><creationdate>20230307</creationdate><title>Kit for detecting early liver cancer</title><author>WEI XUYONG ; WU JIAPING ; XU XIAO ; SU RENYI ; PAN BINHUA ; SHU WENZHI</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_CN115754290A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2023</creationdate><topic>INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES</topic><topic>MEASURING</topic><topic>PHYSICS</topic><topic>TESTING</topic><toplevel>online_resources</toplevel><creatorcontrib>WEI XUYONG</creatorcontrib><creatorcontrib>WU JIAPING</creatorcontrib><creatorcontrib>XU XIAO</creatorcontrib><creatorcontrib>SU RENYI</creatorcontrib><creatorcontrib>PAN BINHUA</creatorcontrib><creatorcontrib>SHU WENZHI</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>WEI XUYONG</au><au>WU JIAPING</au><au>XU XIAO</au><au>SU RENYI</au><au>PAN BINHUA</au><au>SHU WENZHI</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Kit for detecting early liver cancer</title><date>2023-03-07</date><risdate>2023</risdate><abstract>The invention discloses a kit for detecting early liver cancer, relates to the technical field of biomedicine, and determines whether an individual has a liver cancer condition by detecting the levels of ACY1 and GP73 in an individual sample. The two molecules ACY1 and GP73 are used as a combination to detect the expression levels of the two biomolecules in the plasma of a liver cancer individual to be diagnosed, early-stage liver cancer patients can be effectively screened, the combined detection is also sensitive to individuals with negative AFP antibody expression, the detection sensitivity is 94.9%, and the specificity reaches 89.3%.
本发明公开了一种用于检测早期肝癌的试剂盒，涉及生物医学技术领域，其通过检测个体样本中ACY1和GP73的水平来确定个体是否有肝癌状况。本发明将ACY1和GP73这2种分子作为一个组合，检测待确诊肝癌个体血浆中两种生物分子的表达水平，可以有效筛查肝癌早期患者，且该联合检测，对AFP抗体表达阴性的个体也较为灵敏，其检测灵敏度为94.9％，特异性达到89.3％。</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_CN115754290A |
| source | esp@cenet |
| subjects | INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES MEASURING PHYSICS TESTING |
| title | Kit for detecting early liver cancer |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-05T22%3A52%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=WEI%20XUYONG&rft.date=2023-03-07&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ECN115754290A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |